Aemetis Q2 Loss Widens to $8.1M Amid Stagnant Revenue
Ticker: AMTX · Form: 10-Q · Filed: Aug 7, 2025 · CIK: 738214
Sentiment: bearish
Topics: Biofuels, Renewable Energy, Net Loss, Liquidity Risk, Cash Burn, 10-Q Analysis, Small Cap
Related Tickers: AMTX
TL;DR
Aemetis is burning cash and widening losses, making it a risky bet for now.
AI Summary
Aemetis, Inc. (AMTX) reported a net loss of $8.125 million for the three months ended June 30, 2025, a significant increase from the $6.140 million net loss in the prior-year quarter. Revenue for the quarter was $47.771 million, a slight decrease from $47.803 million in the same period last year. The company's total assets stood at $128.880 million as of June 30, 2025, up from $126.593 million at December 31, 2024. Cash and cash equivalents decreased to $0.492 million as of June 30, 2025, from $1.920 million at December 31, 2024, indicating a tightening liquidity position. Total liabilities increased to $113.50 million from $115.42 million. The company continues to face challenges in achieving profitability, with an accumulated deficit of $61.995 million as of June 30, 2025. Strategic outlook remains focused on its renewable fuels projects, but the current financial performance highlights ongoing operational hurdles and capital requirements.
Why It Matters
Aemetis's widening net loss and declining cash position signal increased financial strain, which could impact its ability to fund ongoing renewable energy projects and compete effectively in the highly capital-intensive biofuels market. For investors, this raises concerns about future equity dilution or debt financing, potentially eroding shareholder value. Employees might face uncertainty regarding project timelines and job security if financial performance doesn't improve. Customers could see delays in product development or delivery, while the broader market watches to see if Aemetis can navigate its liquidity challenges amidst fierce competition from larger, more established renewable energy players.
Risk Assessment
Risk Level: high — The company reported a net loss of $8.125 million for Q2 2025, an increase from $6.140 million in Q2 2024, and cash and cash equivalents plummeted from $1.920 million at December 31, 2024, to $0.492 million at June 30, 2025. This significant decline in liquidity, coupled with persistent losses and an accumulated deficit of $61.995 million, indicates substantial financial risk and potential going concern issues.
Analyst Insight
Investors should exercise extreme caution and consider divesting, or at least avoiding new positions, given the widening losses and rapidly depleting cash reserves. Monitor future filings closely for any signs of improved cash flow or successful project financing before considering any investment.
Financial Highlights
- debt To Equity
- N/A
- revenue
- $47.771M
- operating Margin
- N/A
- total Assets
- $128.880M
- total Debt
- $113.50M
- net Income
- -$8.125M
- eps
- N/A
- gross Margin
- N/A
- cash Position
- $0.492M
- revenue Growth
- -0.06%
Key Numbers
- $8.125M — Net Loss (Increased from $6.140M in Q2 2024, indicating worsening profitability.)
- $47.771M — Revenue (Slightly decreased from $47.803M in Q2 2024, showing stagnant top-line growth.)
- $0.492M — Cash and Cash Equivalents (Decreased significantly from $1.920M at year-end 2024, highlighting severe liquidity issues.)
- $128.880M — Total Assets (Slight increase from $126.593M at year-end 2024, but not enough to offset liabilities.)
- $113.50M — Total Liabilities (Slight decrease from $115.42M at year-end 2024, but still high relative to assets.)
- $61.995M — Accumulated Deficit (Indicates a long history of unprofitability and significant retained losses.)
Key Players & Entities
- AEMETIS, INC (company) — filer of the 10-Q
- $8.125 million (dollar_amount) — net loss for Q2 2025
- $6.140 million (dollar_amount) — net loss for Q2 2024
- $47.771 million (dollar_amount) — revenue for Q2 2025
- $47.803 million (dollar_amount) — revenue for Q2 2024
- $0.492 million (dollar_amount) — cash and cash equivalents as of June 30, 2025
- $1.920 million (dollar_amount) — cash and cash equivalents as of December 31, 2024
- $128.880 million (dollar_amount) — total assets as of June 30, 2025
- $113.50 million (dollar_amount) — total liabilities as of June 30, 2025
- $61.995 million (dollar_amount) — accumulated deficit as of June 30, 2025
FAQ
What was Aemetis's net loss for the second quarter of 2025?
Aemetis, Inc. reported a net loss of $8.125 million for the three months ended June 30, 2025, which is an increase from the $6.140 million net loss reported in the same period of 2024.
How did Aemetis's revenue perform in Q2 2025 compared to the previous year?
Aemetis's revenue for the second quarter of 2025 was $47.771 million, a slight decrease from $47.803 million reported in the second quarter of 2024, indicating stagnant top-line performance.
What is Aemetis's current cash position as of June 30, 2025?
As of June 30, 2025, Aemetis, Inc. had cash and cash equivalents of $0.492 million. This represents a significant decrease from $1.920 million at December 31, 2024.
What are the key risks highlighted by Aemetis's Q2 2025 filing?
The key risks include a widening net loss of $8.125 million, rapidly depleting cash reserves of $0.492 million, and a substantial accumulated deficit of $61.995 million, all pointing to significant liquidity and going concern risks.
How have Aemetis's total assets changed since the end of 2024?
Aemetis's total assets increased slightly to $128.880 million as of June 30, 2025, from $126.593 million at December 31, 2024.
What is the significance of Aemetis's accumulated deficit?
Aemetis's accumulated deficit of $61.995 million as of June 30, 2025, signifies that the company has incurred substantial losses since its inception, indicating a persistent challenge in achieving sustained profitability.
What is the outlook for Aemetis given its Q2 2025 financial results?
Given the widening net loss and declining cash position, the outlook for Aemetis appears challenging. The company will need to secure additional financing or significantly improve operational efficiency to fund its strategic renewable fuels projects and achieve profitability.
How do Aemetis's liabilities compare to its assets?
As of June 30, 2025, Aemetis's total liabilities were $113.50 million, while total assets were $128.880 million. This indicates a high leverage ratio and limited equity cushion.
What industry does Aemetis, Inc. operate in?
Aemetis, Inc. operates in the Industrial Organic Chemicals sector, specifically focusing on the production of renewable fuels and biochemicals, as indicated by its Standard Industrial Classification (SIC) code 2860.
What should investors consider regarding Aemetis's stock (AMTX) after this 10-Q filing?
Investors should consider the significant financial risks, including the widening net loss and critically low cash balance. The filing suggests a need for extreme caution, and potential investors should await clear signs of financial improvement or successful capital raises before committing funds.
Risk Factors
- Liquidity Concerns [high — financial]: Cash and cash equivalents significantly decreased to $0.492 million as of June 30, 2025, from $1.920 million at December 31, 2024. This sharp decline indicates potential challenges in meeting short-term obligations and funding ongoing operations.
- Persistent Net Losses [high — financial]: The company reported a net loss of $8.125 million for the three months ended June 30, 2025, an increase from $6.140 million in the prior-year quarter. This trend, coupled with an accumulated deficit of $61.995 million, highlights ongoing profitability issues.
- Stagnant Revenue Growth [medium — operational]: Revenue for the quarter was $47.771 million, a slight decrease from $47.803 million in the same period last year. This lack of top-line growth suggests challenges in expanding market share or increasing sales volume for its products.
- High Debt Levels [medium — financial]: Total liabilities stand at $113.50 million as of June 30, 2025, while total assets are $128.880 million. The significant portion of liabilities relative to assets, especially with a large accumulated deficit, poses financial risk.
- Renewable Fuel Regulations [medium — regulatory]: Aemetis operates in the renewable fuels sector, which is subject to evolving government regulations, subsidies, and mandates. Changes in these policies could materially impact the company's business model and financial performance.
Industry Context
Aemetis operates in the industrial organic chemicals sector, with a specific focus on renewable fuels. This industry is characterized by significant capital investment requirements, technological innovation, and a strong reliance on government policies and incentives. The competitive landscape includes established energy companies and other biofuel producers, all navigating fluctuating commodity prices and evolving environmental regulations.
Regulatory Implications
The renewable fuels industry is heavily influenced by government mandates, tax credits, and environmental regulations. Changes in these policies, such as the Renewable Fuel Standard (RFS) in the U.S. or similar initiatives globally, can significantly impact demand, pricing, and the economic viability of Aemetis's projects.
What Investors Should Do
- Monitor liquidity closely.
- Evaluate progress on renewable fuel projects.
- Analyze cost management and path to profitability.
Glossary
- Accumulated Deficit
- The cumulative net losses of a company that have not been offset by net income in subsequent periods. It represents retained losses. (Aemetis has an accumulated deficit of $61.995 million, indicating a history of unprofitability and a significant need for future earnings to offset these losses.)
- Cash and Cash Equivalents
- Short-term, highly liquid investments that are readily convertible to known amounts of cash and which are subject to an insignificant risk of changes in value. (The sharp decrease to $0.492 million highlights a critical liquidity constraint for Aemetis, potentially impacting its ability to fund operations and meet obligations.)
- Revenue
- The total amount of income generated by the sale of goods or services related to the company's primary operations. (Aemetis reported $47.771 million in revenue for the quarter, showing a slight decline, which indicates a lack of top-line growth.)
- Net Loss
- The total expenses incurred by a company exceed its total revenues over a specific period. (Aemetis reported a net loss of $8.125 million, an increase from the prior year, signaling worsening profitability.)
Year-Over-Year Comparison
Compared to the prior-year quarter, Aemetis, Inc. (AMTX) saw a slight decrease in revenue from $47.803 million to $47.771 million, indicating stagnant top-line performance. More concerning is the widening net loss, which increased from $6.140 million to $8.125 million, signaling deteriorating profitability. While total assets saw a modest increase, the significant drop in cash and cash equivalents from $1.920 million at year-end 2024 to $0.492 million highlights a severe tightening of liquidity, a new and critical risk factor.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on August 7, 2025 regarding AEMETIS, INC (AMTX).